Skip to main content

Table 1 Datasets of Eph/Ephrins in lung cancer (Oncomine)

From: EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma

Gene

Tumor (cases)

Normal (cases)

Fold change

P-value

Dataset

EPHA1

Lung Adenocarcinoma (86)

Lung (10)

1.716

5.67E−10

Beer et al

 

Lung Adenocarcinoma (58)

Lung (58)

1.702

1.78 E−14

Selamat et al

 

Squamous Cell Lung Carcinoma (13)

Lung (6)

1.616

0.002

Garber et al

 

Squamous Cell Lung Carcinoma (27)

Lung (65)

1.878

2.14 E−8

Hou et al

 

Small Cell Lung Carcinoma (6)

Lung (17)

− 4.424

3.63 E−5

Bhattacharjee et al

EPHA2

Large Cell Lung Carcinoma (19)

Lung (65)

− 3.583

7.45 E−13

Hou et al

 

Small Cell Lung Carcinoma (4)

Lung (6)

− 2.827

0.009

Garber et al

EPHA10

Lung Adenocarcinoma (226)

Lung (20)

4.732

5.65 E−10

Okayama et al

EFNA1

Squamous Cell Lung Carcinoma (34)

Lung (2); Tongue (26)

2.181

3.32 E−10

Talbot et al

 

Lung Carcinoid Tumor (20)

Lung (17)

− 65.441

5.13 E−9

Bhattacharjee et al

EFNA3

Lung Adenocarcinoma (27)

Lung (30)

4.604

2.17 E−8

Su et al

 

Squamous Cell Lung Carcinoma (27)

Lung (65)

1.934

9.04 E−17

Hou et al

 

Large Cell Lung Carcinoma (19)

Lung (65)

1.943

1.88 E−7

Hou et al

 

Lung Adenocarcinoma (86)

Lung (10)

1.791

2.70 E−4

Beer et al

EFNA4

Lung Adenocarcinoma (45)

Lung (65)

2.504

1.35 E−17

Hou et al

 

Squamous Cell Lung Carcinoma (27)

Lung (65)

2.20

1.04 E−12

Hou et al

 

Lung Adenocarcinoma (58)

Lung (58)

1.722

1.27 E−21

Selamat et al

 

Lung Adenocarcinoma (27)

Lung (30)

3.720

2.97 E−8

Su et al

 

Lung Adenocarcinoma (58)

Lung (49)

2.137

2.98 E−17

Landi et al

 

Squamous Cell Lung Carcinoma (5)

Lung (6)

1.858

3.72 E−4

Wachi et al

 

Lung Adenocarcinoma (226)

Lung (20)

2.423

8.49 E−15

Okayama et al

 

Lung Adenocarcinoma (20)

Lung (19)

2.723

1.27 E−5

Stearman et al

EPHB1

Large Cell Lung Carcinoma (4)

Lung (6)

2.833

0.001

Garber et al

 

Lung Adenocarcinoma (36)

Lung (6)

2.608

1.01 E−4

Garber et al

 

Squamous Cell Lung Carcinoma (12)

Lung (6)

3.360

1.35 E−4

Garber et al

 

Small Cell Lung Carcinoma (4)

Lung (6)

4.877

0.010

Garber et al

 

Squamous Cell Lung Carcinoma, Basaloid Variant (8)

Lung (390)

1.543

5.08 E−4

TCGA

 

Lung Adenocarcinoma (38)

Lung (6)

− 2.966

4.77 E−6

Garber et al

EPHB2

Lung Adenocarcinoma (20)

Lung (19)

1.947

1.15 E−7

Stearman et al

 

Lung Adenocarcinoma (27)

Lung (30)

2.958

7.60 E−7

Su et al

 

Lung Adenocarcinoma (45)

Lung (65)

1.539

1.22 E−11

Hou et al

 

Lung Adenocarcinoma (58)

Lung (49)

1.594

6.46 E−13

Landi et al

 

Lung Adenocarcinoma (132)

Lung (17)

2.006

0.015

Bhattacharjee et al

 

Lung Adenocarcinoma (226)

Lung (20)

2.400

1.02 E−10

Okayama et al

 

Lung Adenocarcinoma (86)

Lung (10)

− 2.372

2.95 E−6

Beer et al

EPHB3

Squamous Cell Lung Carcinoma, Basaloid Variant (8)

Lung (390)

1.721

1.21 E−4

TCGA

 

Squamous Cell Lung Carcinoma (348)

Lung (390)

1.560

1.29 E−87

TCGA

 

Squamous Cell Lung Carcinoma (11)

Lung (3)

1.779

0.004

Yamagata et al

 

Large Cell Lung Carcinoma (5)

Lung (3)

1.563

0.014

Yamagata et al

 

Squamous Cell Lung Carcinoma (13)

Lung (6)

4.747

7.31 E−5

Garber et al

 

Squamous Cell Lung Carcinoma (21)

Lung (17)

5.147

6.27 E−4

Bhattacharjee et al

 

Squamous Cell Lung Carcinoma (5)

Lung (6)

1.573

0.001

Wachi et al

 

Lung Adenocarcinoma (20)

Lung (19)

1.797

1.29 E−4

Stearman et al

 

Squamous Cell Lung Carcinoma (27)

Lung (65)

2.130

5.56 E−10

Hou et al

 

Lung Adenocarcinoma (45)

Lung (65)

1.554

4.02 E−9

Hou et al

 

Large Cell Lung Carcinoma (19)

Lung (65)

1.899

3.11 E−5

Hou et al

 

Lung Adenocarcinoma (226)

Lung (20)

1.731

1.24 E−8

Okayama et al

EPHB4

Small Cell Lung Carcinoma (6)

Lung (17)

− 6.614

3.49 E−6

Bhattacharjee et al

EPHB6

Large Cell Lung Carcinoma (3)

Lung (6)

− 1.542

0.003

Garber et al

 

Lung Adenocarcinoma (39)

Lung (6)

− 1.708

4.32 E−4

Garber et al

 

Small Cell Lung Carcinoma (6)

Lung (17)

− 4.770

3.28 E−5

Bhattacharjee et al

 

Lung Adenocarcinoma (20)

Lung (19)

− 3.105

1.18 E−4

Stearman et al

EFNB1

Lung Adenocarcinoma (20)

Lung (19)

− 1.789

4.73 E−8

Stearman et al

 

Lung Carcinoid Tumor (20)

Lung (17)

− 16.859

8.76 E−7

Bhattacharjee et al

 

Small Cell Lung Carcinoma (6)

Lung (17)

− 3.585

8.46 E−5

Bhattacharjee et al

 

Large Cell Lung Carcinoma (4)

Lung (6)

− 1.592

0.017

Garber et al

EFNB2

Lung Adenocarcinoma (132)

Lung (17)

− 3.676

1.56 E−6

Bhattacharjee et al

 

Lung Carcinoid Tumor (20)

Lung (17)

− 9.762

6.10 E−10

Bhattacharjee et al

 

Squamous Cell Lung Carcinoma (21)

Lung (17)

− 2.156

0.009

Bhattacharjee et al

 

Lung Adenocarcinoma (20)

Lung (19)

− 2.453

2.77E−6

Stearman et al

 

Lung Adenocarcinoma (58)

Lung (49)

− 2.304

5.93E−17

Landi et al

 

Lung Adenocarcinoma (27)

Lung (30)

− 2.044

2.96E−6

Su et al

 

Large Cell Lung Carcinoma (19)

Lung (65)

− 3.549

9.56 E−10

Hou et al

 

Squamous Cell Lung Carcinoma (5)

Lung (5)

− 1.917

0.004

Wachi et al

 

Lung Adenocarcinoma (58)

Lung (58)

− 1.988

2.48 E−10

Selamat et al

EFNB3

Lung Carcinoid Tumor (20)

Lung (17)

4.500

1.58 E−5

Bhattacharjee et al